UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): APRIL 6, 2004
IR BIOSCIENCES HOLDINGS, INC.
(EXACT NAME OF REGISTRANT SPECIFIED IN CHARTER)
DELAWARE 033-05384 13-3301899
(STATE OF INCORPORATION) (COMMISSION FILE NUMBER) (IRS EMPLOYER
IDENTIFICATION NO.)
8655 EAST VIA DE VENTURA, SUITE E-155
--------------------------------------------------------------------------------
SCOTTSDALE, ARIZONA 85258
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
(480) 922-3926
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
--------------------------------------------------------------------------------
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
ITEM 5. OTHER EVENTS.
On April 6, 2004, IR Biosciences Holdings, Inc. (the "Registrant")
issued a press release announcing a two-for-one forward split of its
common stock, which was effective as of the opening of the markets
on April 6, 2004. In connection with the forward stock split, the
Registrant's trading symbol on the Over-the-Counter Bulletin Board
changed from "IRBH" to "IRBO." A copy of the press release is
attached as Exhibit 99.1 to this report.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits:
99.1 Press Release dated April 6, 2004 announcing the Registrant's
two-for-one forward split of its common stock.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IR BIOSCIENCES HOLDINGS, INC.
By: /s/ Michael Wilhelm
-----------------------------
Michael Wilhelm, President
Dated: April 7, 2004
EXHIBIT INDEX
99.1 Press Release dated April 6, 2004 announcing the Registrant's
two-for-one forward split of its common stock.